Nwam LLC Sells 2,423 Shares of Danaher Co. (NYSE:DHR)

Nwam LLC lowered its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 18.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 10,746 shares of the conglomerate's stock after selling 2,423 shares during the period. Nwam LLC's holdings in Danaher were worth $2,467,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher in the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher in the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC boosted its position in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on DHR. Citigroup cut their price target on shares of Danaher from $285.00 to $265.00 and set a "buy" rating on the stock in a report on Thursday, January 30th. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $310.00 to $300.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. StockNews.com lowered shares of Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, December 14th. Robert W. Baird lowered their price target on shares of Danaher from $277.00 to $268.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Finally, Scotiabank began coverage on Danaher in a report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price objective for the company. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $278.00.

Danaher Price Performance

NYSE:DHR traded down $2.16 during trading hours on Monday, hitting $205.60. The stock had a trading volume of 3,222,948 shares, compared to its average volume of 4,547,969. The company has a 50 day simple moving average of $224.58 and a two-hundred day simple moving average of $244.76. The firm has a market capitalization of $146.94 billion, a price-to-earnings ratio of 38.94, a P/E/G ratio of 2.66 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the business earned $2.09 earnings per share. Research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. This is a boost from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher's dividend payout ratio is 24.24%.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company's stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.